Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Jan 29;308(6924):321–328. doi: 10.1136/bmj.308.6924.321

Diagnosis and management of heart failure.

H J Dargie 1, J J McMurray 1
PMCID: PMC2539274  PMID: 7907244

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnett D. B. Diagnosis of symptomless left ventricular dysfunction. Lancet. 1993 May 1;341(8853):1124–1125. doi: 10.1016/0140-6736(93)93132-k. [DOI] [PubMed] [Google Scholar]
  2. Barnett D. B. Flosequinan. Lancet. 1993 Mar 20;341(8847):733–736. doi: 10.1016/0140-6736(93)90498-6. [DOI] [PubMed] [Google Scholar]
  3. Chadda K., Goldstein S., Byington R., Curb J. D. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 1986 Mar;73(3):503–510. doi: 10.1161/01.cir.73.3.503. [DOI] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleland J. G., Henderson E., McLenachan J., Findlay I. N., Dargie H. J. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol. 1991 Mar 1;17(3):733–739. doi: 10.1016/s0735-1097(10)80192-5. [DOI] [PubMed] [Google Scholar]
  7. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  9. Creager M. A., Massie B. M., Faxon D. P., Friedman S. D., Kramer B. L., Weiner D. A., Ryan T. J., Topic N., Melidossian C. D. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol. 1985 Jul;6(1):163–173. doi: 10.1016/s0735-1097(85)80269-2. [DOI] [PubMed] [Google Scholar]
  10. Feldman A. M., Bristow M. R., Parmley W. W., Carson P. E., Pepine C. J., Gilbert E. M., Strobeck J. E., Hendrix G. H., Powers E. R., Bain R. P. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15;329(3):149–155. doi: 10.1056/NEJM199307153290301. [DOI] [PubMed] [Google Scholar]
  11. Fryback D. G., Dasbach E. J., Klein R., Klein B. E., Dorn N., Peterson K., Martin P. A. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993 Apr-Jun;13(2):89–102. doi: 10.1177/0272989X9301300202. [DOI] [PubMed] [Google Scholar]
  12. Kleber F. X., Niemöller L., Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J. 1992 Apr;67(4):289–296. doi: 10.1136/hrt.67.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kraus F., Rudolph C., Rudolph W. Wirksamkeit von Digitalis bei Patienten mit chronischer Herzinsuffizienz und Sinusrhythmus. Ubersicht über randomisiert, doppelblind und placebokontrolliert durchgeführte Studien. Herz. 1993 Apr;18(2):95–117. [PubMed] [Google Scholar]
  14. McKee P. A., Castelli W. P., McNamara P. M., Kannel W. B. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971 Dec 23;285(26):1441–1446. doi: 10.1056/NEJM197112232852601. [DOI] [PubMed] [Google Scholar]
  15. McMurray J., Dargie H. J. ACE inhibitors for myocardial infarction and unstable angina. Lancet. 1992 Dec 19;340(8834-8835):1547–1548. doi: 10.1016/0140-6736(92)92803-n. [DOI] [PubMed] [Google Scholar]
  16. Mehta D., Saksena S., Krol R. B. Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use. Am Heart J. 1992 Dec;124(6):1608–1614. doi: 10.1016/0002-8703(92)90080-f. [DOI] [PubMed] [Google Scholar]
  17. Mujais S. K., Nora N. A., Levin M. L. Principles and clinical uses of diuretic therapy. Prog Cardiovasc Dis. 1992 Nov-Dec;35(3):221–245. doi: 10.1016/0033-0620(92)90013-p. [DOI] [PubMed] [Google Scholar]
  18. Murphy M. B., Elliott W. J. Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit Care Med. 1990 Jan;18(1 Pt 2):S14–S18. [PubMed] [Google Scholar]
  19. Nolan J., Bloomfield P. Non-rheumatic atrial fibrillation: warfarin or aspirin for all? Br Heart J. 1992 Dec;68(6):544–548. doi: 10.1136/hrt.68.12.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pacher R., Globits S., Bergler-Klein J., Teufelsbauer H., Wutte M., Baumgartner W., Ogris E., Glogar D. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J. 1993 Feb;14(2):273–278. doi: 10.1093/eurheartj/14.2.273. [DOI] [PubMed] [Google Scholar]
  21. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  22. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  23. Riegger G. A. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J. 1991 Jun;12(6):705–711. doi: 10.1093/eurheartj/12.6.705. [DOI] [PubMed] [Google Scholar]
  24. Smith T. W. Digoxin in heart failure. N Engl J Med. 1993 Jul 1;329(1):51–53. doi: 10.1056/NEJM199307013290111. [DOI] [PubMed] [Google Scholar]
  25. Stewart A. L., Greenfield S., Hays R. D., Wells K., Rogers W. H., Berry S. D., McGlynn E. A., Ware J. E., Jr Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989 Aug 18;262(7):907–913. [PubMed] [Google Scholar]
  26. Sutton G. C. Epidemiologic aspects of heart failure. Am Heart J. 1990 Dec;120(6 Pt 2):1538–1540. doi: 10.1016/0002-8703(90)90055-3. [DOI] [PubMed] [Google Scholar]
  27. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  28. Uretsky B. F., Jessup M., Konstam M. A., Dec G. W., Leier C. V., Benotti J., Murali S., Herrmann H. C., Sandberg J. A. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation. 1990 Sep;82(3):774–780. doi: 10.1161/01.cir.82.3.774. [DOI] [PubMed] [Google Scholar]
  29. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975 Oct;37(10):1022–1036. doi: 10.1136/hrt.37.10.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES